Document is current

Any future updates will be listed below

Killer immunoglobulin-like receptor (KIR) and KIR–ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2

Crossref DOI link: https://doi.org/10.1007/s00262-016-1904-8

Published Online: 2016-09-30

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark